Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Merit E. Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner, Hiroshi Mitsumoto, Jesus S. Mora, Albert Ludolph, Orla Hardiman, Michael E. Bozik, Evan W. Ingersoll, Donald Archibald, Adam L. Meyers, Yingwen Dong, Wildon R. Farwell, Douglas A. Kerr, Karen Morrison

Research output: Contribution to journalArticlepeer-review

148 Citations (Scopus)

Fingerprint Dive into the research topics of 'Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences